With its ability to enhance predictive accuracy, quantum computing may significantly lower R&D costs in pharmaceuticals by reducing candidate failures.
The agreement gives MSD (known as Merck & Co in the US and Canada) access to the Mayo Clinic Platform architecture – which covers de-identified laboratory results, medical imaging, clinical notes, ...